Learn More
Medchemexpress LLC Oxidopamine (hydrobromide) | 636-00-0 | 99.4% | 50 MG

Supplier: Medchemexpress LLC HYB1081A50MG
Oxidopamine (6-OHDA) hydrobromide is a neurotoxin that selectively destroys dopaminergic neurons and acts as an antagonist of the neurotransmitter dopamine. It promotes COX-2 activation, leading to PGE2 synthesis and pro-inflammatory cytokine IL-1β secretion. This compound is used in research for Parkinson's disease (PD), attention-deficit hyperactivity disorder (ADHD), and Lesch-Nyhan syndrome.
- Antagonist of the neurotransmitter dopamine.
- Selectively destroys dopaminergic neurons.
- Promotes COX-2 activation, leading to PGE2 synthesis and pro-inflammatory cytokine IL-1β secretion.
- Used for research of Parkinson's disease (PD), attention-deficit hyperactivity disorder (ADHD), and Lesch-Nyhan syndrome.
- Can induce Parkinson's disease models.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.